Publications | Lund University Publications

121 – 130 of 192

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+%22af7e247a-381e-4a1c-a1d8-7625b1488a9e%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
12
13
14
15
…
20
next »

2009
Mark Arandomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study.
Astermark, Jan ^LU ; Donfield, Sh M. ; DiMichele, D. M. ; Gringeri, A. ; Gilbert, S. A. ; Waters, J. and Berntorp, Erik ^LU (2009) In Gematologiâ i Transfuziologiâ 54(5). p.35-35
- Contribution to journal › Article
Mark Characterization of a Novel Aberrant Splice Site, 79bp Downstream of Exon 5 in the Human Factor 7 Gene Detected in Patients with Severe Congenital Factor VII Deficiency.
Wulff, Karin ; Astermark, Jan ^LU ; Herrmann, Falko F. H. ; Auerswald, Guenther and Schroeder, Winnie (2009) 51st Annual Meeting of the American-Society-of-Hematology In Blood 114(22). p.1351-1351
- Contribution to journal › Published meeting abstract
Mark Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
Pavlova, A. ; Delev, D. ; Lacroix-Desmazes, S. ; Schwaab, R. ; Mende, M. ; Fimmers, R. ; Astermark, Jan ^LU and Oldenburg, J. (2009) In Journal of Thrombosis and Haemostasis 7(12). p.2006-2015
- Contribution to journal › Article
Mark Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
Salvagno, G. L. ; Astermark, Jan ^LU ; Lippi, G. ; Ekman, Maj ^LU ; Franchini, M. ; Guidi, G. C. and Berntorp, Erik ^LU (2009) In Haemophilia 15(1). p.290-296
- Contribution to journal › Article
Mark Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy
Groevdal, M. ; Kahn, R. ; Jansson, M. ; Aggerholm, A. ; Antunovic, P. ; Astermark, Jan ^LU ; Bernell, P. ; Engstroem, L. ; Kjeldsen, L. and Linder, O. , et al. (2009) 10th International Symposium on Myelodysplastic Syndromes In Leukemia Research 33(Suppl 1). p.49-50
- Contribution to journal › Published meeting abstract
Mark Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
Collins, P. W. ; Blanchette, V. S. ; Fischer, K. ; Bjorkman, S. ; Oh, M. ; Fritsch, S. ; Schroth, P. ; Spotts, G. ; Astermark, Jan ^LU and Ewenstein, B. (2009) In Journal of Thrombosis and Haemostasis 7(3). p.413-420
- Contribution to journal › Article
Mark Cumulative incidence of inhibitors: it is influenced by type of replacement therapy in previously treated boys with severe haemophilia A. No
Astermark, Jan ^LU (2009) In Haemophilia 15(2). p.623-623
- Contribution to journal › Published meeting abstract
Mark Genetic Factors Associated with Inhibitor Development in Hemophilia A: Initial Results From the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Astermark, Jan ^LU ; Schwarz, John ; Donfield, Sharyne M. ; DiMichele, Donna M. ; Ewenstein, Bruce M. ; Gomperts, Edward D. ; Nelson, George W. ; Oldenburg, Johannes ; Shapiro, Amy D. and Spotts, Gerald , et al. (2009) 51st Annual Meeting of the American-Society-of-Hematology In Blood 114(22). p.95-95
- Contribution to journal › Published meeting abstract
Mark European curriculum for thrombosis and haemostasis.
Astermark, Jan ^LU ; Negrier, C ; Hermans, C ; Holme, P A ; Klamroth, R ; Kotsi, P ; de Moerloose, P ; Pasi, J ; Rocino, A and von Depka, M , et al. (2009) In Haemophilia 15(1). p.337-344
- Contribution to journal › Article
2008
Mark Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
Grovdal, Michael ; Khan, Rasheed ; Aggerholm, Anni ; Antunovic, Petar ; Astermark, Jan ^LU ; Bernell, Per ; Engstroem, Lena-Maria ; Kjeldsen, Lars ; Linder, Olle and Nilsson, Lars , et al. (2008) 50th Annual Meeting of the American- Society-of-Hematology In Blood 112(11). p.89-89
- Contribution to journal › Published meeting abstract

« previous
1
…
12
13
14
15
…
20
next »

your query:: Remove author: Astermark, Jan (LU)